MORTALITY FOLLOWING INITIATION OR DISCONTINUATION OF GUIDELINE DIRECTED MEDICAL THERAPIES IN HOSPITALIZED HEART FAILURE PATIENTS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY

MORTALITY FOLLOWING INITIATION OR DISCONTINUATION OF GUIDELINE DIRECTED MEDICAL THERAPIES IN HOSPITALIZED HEART FAILURE PATIENTS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY

Initiate versusNever Discontinue versusMaintain Initiate versusNever Discontinue versusMaintain ACEI/ARB 0.60 (0.44-0.81) 1.20 (0.84-1.73) 0.56 (0.37-0.85) 1.74 (1.29-2.34) Beta blocker 0.46 (0.33-0.63) 1.28 (0.75-2.16) 0.94 (0.63-1.42) 1.31 (0.94-1.83) Aldosterone blocker 0.69 (0.44-1.08) 1.67 (0.8...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.1549-1549
Hauptverfasser: Tran, Richard, Aldemerdash, Ahmed, Chang, Patricia, Sueta, Carla, Kaufman, Brystana, Asafu-Adjei, Josephine, Vardeny, Orly, Daubert, Eliza, Kucharska-Newton, Anna, Stearns, Sally, Rodgers, Jo
Format: Artikel
Sprache:eng
Schlagworte:
Atherosclerosis
Cardiology
Cardiovascular
Confidence intervals
Heart failure
Hospitalization
Internal Medicine
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Initiate versusNever Discontinue versusMaintain Initiate versusNever Discontinue versusMaintain ACEI/ARB 0.60 (0.44-0.81) 1.20 (0.84-1.73) 0.56 (0.37-0.85) 1.74 (1.29-2.34) Beta blocker 0.46 (0.33-0.63) 1.28 (0.75-2.16) 0.94 (0.63-1.42) 1.31 (0.94-1.83) Aldosterone blocker 0.69 (0.44-1.08) 1.67 (0.83-3.38) 0.98 (0.63-1.54) 1.01 (0.57-1.82) Digoxin 0.49 (0.32-0.77) 1.01 (0.54-1.90) 0.87 (0.57-1.35) 1.18 (0.74-1.88) Data are presented as odds ratios (95% Confidence Interval) ACEI = angiotensin converting enzyme inhibitor, ARB = angiotensin receptor blocker
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)31550-9